ClinicalTrials.gov
ClinicalTrials.gov Menu

Merging Yoga and Occupational Therapy for Parkinson Disease: Phase 2 (MY-OT for PD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03578653
Recruitment Status : Enrolling by invitation
First Posted : July 6, 2018
Last Update Posted : February 6, 2019
Sponsor:
Information provided by (Responsible Party):
Colorado State University

Brief Summary:
The full program is focused on identifying and reducing risk factors surrounding falls. Based on previous research, we believe that occupational therapy group classes and adaptive yoga are an ideal pairing to reduce fall risk. The occupational therapy sessions will consist of lecture, group discussion, and activities designed to target biological, behavioral, environmental, and socioeconomic factors that contribute to fall risk specifically for people with Parkinson's disease.

Condition or disease Intervention/treatment Phase
Parkinson Disease Behavioral: Merging Yoga and Occupational Therapy for Parkinson disease Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 18 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Merging Yoga and Occupational Therapy for Parkinson Disease: Phase 2
Actual Study Start Date : June 1, 2018
Actual Primary Completion Date : December 31, 2018
Estimated Study Completion Date : October 31, 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Merging Yoga and Occupational Therapy for Parkinson disease
The group participates in three assessment periods: August, October, and December. Then in October-December the group will receive group occupational therapy and recommended community adaptive yoga programming 2x/week for 8 weeks.
Behavioral: Merging Yoga and Occupational Therapy for Parkinson disease
The group occupational therapy portion focuses on lecture, group discussion, and activities to reduce fall risk. The yoga program is part of an ongoing community yoga program specifically designed for people with Parkinson disease.




Primary Outcome Measures :
  1. Change in Fall Risk Factor Management [ Time Frame: Baseline, Pre-assessment (8-weeks after baseline), and post-assessment (8-weeks after pre-assessment) ]
    Self-report 5 scales measuring the ability to manage fall risk factors



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Individuals with a diagnosis of Parkinson's disease OR their care partners
  • Individuals who read and understand English
  • Individuals who can stand with or without an assistive device
  • People who are willing to commit to yoga practice 2x/week for 8 weeks and pay $5/class through Raintree Athletic Club (Scholarships are available if needed!)
  • People who are willing to commit to group occupational therapy 2x/week for 8 weeks free of charge
  • score of at least 4/6 on the short mini mental status exam

Exclusion Criteria:

  • less than 18 years of age

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03578653


Locations
United States, Colorado
Colorado State University
Fort Collins, Colorado, United States, 80521
Sponsors and Collaborators
Colorado State University
Investigators
Principal Investigator: Laura Grimm, MS Colorado State University

Responsible Party: Colorado State University
ClinicalTrials.gov Identifier: NCT03578653     History of Changes
Other Study ID Numbers: 17-7398H
First Posted: July 6, 2018    Key Record Dates
Last Update Posted: February 6, 2019
Last Verified: February 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases